针对线粒体功能障碍,干预肝癌的发生
Maomao Li1, Siyao Liang1, Le Chang1
1Yan'an Key Laboratory of Microbial Drug Innovation and Transformation, Yan'an Medical School of Yan'an University, Yan'an 716000, China.
Cancer biology & medicine
|September 10, 2025
概括
线粒体功能障碍驱动肝癌的进展和耐药性. 准这些线粒体缺陷为改善肝癌治疗结果提供了一个有希望的新途径.
科学领域:
- 肝细胞癌研究 肝细胞癌研究
- 线粒体生物学 线粒体生物学
- 癌症的代谢 癌症的代谢
背景情况:
- 线粒体功能障碍是肝癌发生和进展的关键驱动因素.
- 线粒体调节能量代谢 (沃伯格效应) 和亡,影响瘤增殖和耐药性.
- 线粒体DNA突变和 mitoophagy 损伤加剧了肝癌的侵入性和转移.
研究的目的:
- 审查线粒体功能障碍在肝癌中的作用.
- 讨论针对线粒体的当前治疗策略.
- 突出肝癌治疗中精准医学的未来方向.
主要方法:
- 对肝癌中线粒体功能障碍研究的文献综述.
- 分析当前的有针对性的治疗策略.
- 讨论挑战和未来的研究方向.
主要成果:
- 线粒体功能障碍,包括改变的氧化酸化和反应性氧物种的积累,促进肝癌.
- mtDNA突变和线粒细胞的失调增强了癌症的入侵潜力.
- 目前针对线粒体通路的治疗方法有希望,但面临着异质性和耐药性等挑战.
结论:
- 针对线粒体功能障碍是肝癌治疗的关键策略.
- 未来的研究应该专注于精准医学,向性治疗,组合疗法和生物标志物.
- 针对线粒体的进步有可能显著改善肝癌患者的预后.
相关概念视频
01:46Electron Transport Chain: Complex I and II
18.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.5K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K